KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Tax Provisions (2021 - 2025)

Novavax (NVAX) has 8 years of Tax Provisions data on record, last reported at $376000.0 in Q4 2025.

  • For Q4 2025, Tax Provisions fell 94.95% year-over-year to $376000.0; the TTM value through Dec 2025 reached $1.9 million, down 82.86%, while the annual FY2025 figure was $1.9 million, 82.86% down from the prior year.
  • Tax Provisions reached $376000.0 in Q4 2025 per NVAX's latest filing, up from -$657000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $16.6 million in Q4 2021 and bottomed at -$2.3 million in Q4 2022.
  • Average Tax Provisions over 5 years is $2.4 million, with a median of $1.6 million recorded in 2022.
  • Peak YoY movement for Tax Provisions: plummeted 128.2% in 2023, then soared 1641.96% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $16.6 million in 2021, then crashed by 113.61% to -$2.3 million in 2022, then soared by 174.69% to $1.7 million in 2023, then surged by 341.29% to $7.4 million in 2024, then crashed by 94.95% to $376000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $376000.0 in Q4 2025, -$657000.0 in Q3 2025, and $946000.0 in Q2 2025.